St. Louis VC firm RiverVest closes on $74m second fund
The Missouri biotech-focussed firm has beaten its previous fund by $30m.
The Missouri biotech-focussed firm has beaten its previous fund by $30m.
Copyright PEI Media
Not for publication, email or dissemination